JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (4): 1-5.doi: 10.6040/j.issn.1671-7554.0.2014.666

    Next Articles

Galectin-9 inhibits proliferation and migration of glioma cells

YAO Zhong1, CHEN Weiliang1, XU Yangyang1, HE Ying2, QU Xun2, LI Xingang1   

  1. 1. Department of Neurosurgery, Qilu Hospital of Shandong University, Brain Science Research Institute, Shandong University, Jinan 250012, Shandong, China;
    2. Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2014-10-08 Revised:2014-12-23 Online:2015-04-10 Published:2015-04-10

PDF (PC)

424

Abstract: Objective To investigate the effects of exogenous galectin-9 on the proliferation and migration of glioma cells and its potential mechanism. Methods The expression of galectin-9 in glioma cells was detected with real-time quantitative polymerase chain reaction (PCR). After glioma cell line U251 was treated with different concentrations of exogenous galectin-9 (1, 4, 8, 16 μg/mL), the changes of proliferation and migration were tested with cell count kit-8 (CCK-8) and transwell chambers respectively at different time (12, 24, 36 h). When the competitive inhibitor lactose was added, the changes in proliferation and migration were detected. Results The expression of galectin-9 in 4 glioma cell lines was low or barely detected. Cells treated with 8 and 16 μg/mL galectin-9 showed decreased cell proliferation rates, compared with control group (P <0.001). With time passing by, the cell proliferation rate decreased gradually (P <0.01). After lactose treatment, cell proliferation rate increased (P <0.05). Galectin-9 treatment significantly reduced the numbers of cells penetrating the micropomus membrane (P <0.01), while lactose treatment increased the number of cells, compared with the untreated group (P<0.05). Conclusion Galectin-9 effectively inhibits proliferation of glioma cells in a time- and dose-dependent manner, and it can also inhibit the migration of glioma cells.

Key words: Proliferation, Migration, Glioma, Galectin-9

CLC Number: 

  • R739.4
[1] Hirashima M, Kashio Y, Nishi N, et al. Galectin-9 in physiological and pathological conditions[J]. Glycoconjugate Journal, 2004, 19(7-9):593-600.
[2] Matsumoto R, Matsumoto H, Seki M, et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes[J]. J Biol Chem, 1998, 273(27):16976-16984.
[3] Kobayashi T, Kuroda J, Ashihara E, et al. Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways[J]. Leukemia, 2010, 24(4):843-850.
[4] Nobumoto A, Nagahara K, Oomizu S, et al. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices[J]. Glycobiology, 2008, 18(9):735-744.
[5] Zhang ZY, Dong JH, Chen YW, et al. Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma[J]. Asian Pacific J Cancer Prev, 2012, 13(6):2503-2509.
[6] 顾长江, 吴寒盛, 陈毅, 等. 半乳凝素9在肝细胞肝癌患者中的表达及其与预后的关系[J]. 中华医学杂志, 2013, 93(26):2025-2028. GU Changjiang, WU Hansheng, CHEN Yi, et al. Expression and prognostic value of galectin-9 in hepatocellular carcinoma patients[J]. National Medical Journal of China, 2013, 93(26):2025-2028.
[7] 郭素平, 马军, 唐芙爱, 等. 食管鳞状细胞癌组织中Galectin-9和MMP-2蛋白的表达及与预后的关系[J]. 郑州大学学报:医学版, 2012, 47(6):749-752. GUO Suping, MA Jun, TANG Fuai, et al. Relationship between prognosis and expressions of Galectin-9 and MMP-2 in esophageal squamous cell carcinoma tissue[J]. Journal of Zhengzhou University: Medical Sciences, 2012, 47(6):749-752.
[8] Lahm H, André S, Hoeflich A, et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by PT-PCR and its implications for diagnostic and therapeutic procedures[J]. J Cancer Res Clin Oncol, 2001, 127(6):375-386.
[9] Matsumoto R, Matsumoto H, Seki M, et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes[J]. J Biol Chem, 1998, 273(27):16976-16984.
[10] Jiang J, Jin MS, Kong F, et al. Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer[J]. PLoS One, 2013, 8(12):e81799. doi:10.1371/journal.pone.0081799. eCollection 2013.
[11] Steelman AJ, Smith R 3rd, Welsh CJ, et al. Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis[J]. J Biol Chem, 2013, 288(33):23776-23787.
[12] Yoshida H, Imaizumi T, Kumagai M, et al. Interleukin-1beta stimulates galectin-9 expression in human astrocytes[J]. Neuroreport, 2001, 12(17):3755-3758.
[13] Wiersma VR, Bruyn M, Ginkel RJ, et al. The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells[J]. Journal of Investigative Dermatology, 2012, 132(9):2302-2305.
[14] Irie A, Yamauchi A, Kontani K, et al. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer[J]. Clin Cancer Res, 2005, 11(8):2962-2968.
[15] Miyanishi N, Nishi N, Abe H, et al. Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family[J]. Glycobiology, 2007, 17(4):423-432.
[16] Ishikawa A, Imaizumi T, Yoshida H, et al. Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells[J]. Immunol Cell Biol, 2004, 82(4):410-414.
[1] WANG Xiao-Lei, ZHANG Hai-Thao, ZHANG Hui, GUO Cheng-Hao. Protective effects of shuxuening injecta on vascular  endothelial  cell injury in vitro due to iodine excesses [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 38-.
[2] WANG Lin-Lin, SUN Mei-Li, SUN Yu-Ping, ZHANG Nan, LIU Chuan-Yong. Expressions of α-Tubulin and γ-Tubulin in human Glioma and their relation with Survivin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 103-.
[3] SUN Yifeng, GAO Yu, LIANG Yongyuan, GAO Yang. Expression of CPLX2 and its in vitro effects on the proliferation migration and invasion of hepatocellular carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 34-39.
[4] Gang LI,Hao XUE,Wei QIU,Rongrong ZHAO. Research advances in the formation of glioma immunosuppressive microenvironment [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 67-73.
[5] Qiang WU,Zekun HE,Ju LIU,Xiaomeng CUI,Shuang SUN,Wei SHI. A research on multi-modal MRI analysis based on machine learning for brain glioma [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 81-87.
[6] Anjing CHEN,Xun ZHANG. The new strategies of targeting SUMOylation in the treatment of glioma [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 88-94.
[7] Tao JIANG. The application of brain-like intelligence in the frontiers of brain science [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 10-13.
[8] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32-37.
[9] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38-46.
[10] XU Jixi, CHEN Weijian. Diffuse midline glioma with H3 K27M mutation in the spinal cord: a case report [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 96-101.
[11] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7-14.
[12] WANG Kaimin, TAN Juanjuan, YAN Zhiqiang, LI Zhiqiang. Effects of Sirtuin on hypoxia-induced proliferation of human umbilical cord-derived mesenchymal stem cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 23-30.
[13] SHI Peikun, ZENG Beini, WU Weifang, HU Xiaoyan, MA Tianjia, ZHOU Yabin. Expression and role of Keap1 in renal cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 94-99.
[14] SUN Zeyu, CHEN Ying, LIN Jiaxiang, LIU Juan, ZHAO Weiming. Influence of inositol polyphosphate-4-phosphatase type II on the proliferation and apoptosis of cervical cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 1-6.
[15] WANG Chaochao, TIAN Hailong, JIANG Huifeng, GUO Wenqiang, WANG Zhigang. Clinical significance of sodium fluorescein-guided resection of high-grade glioma under “yellow fluorescence” mode [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 32-37.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd